Another systematic review included four studies, which involved in 187 histologically confirmed NASH adult patients, revealed that Thiazolidinediones treatment increases circulating adiponectin levels as well as histological improvement in NASH patients [27]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.